M&A Deal Summary

eMolecules Acquires Synple

On September 24, 2024, eMolecules acquired chemicals company Synple

Acquisition Highlights
  • This is eMolecules’ 1st transaction in the Chemicals sector.
  • This is eMolecules’ 1st transaction in Switzerland.

M&A Deal Summary
Date 2024-09-24
Target Synple
Sector Chemicals
Buyer(s) eMolecules
Deal Type Add-on Acquisition

Target

Synple

Kemptthal, Switzerland
Synple specializes in automated chemical synthesis systems and solutions for small molecules drug discovery customers. Synple was formed in 2016 and is headquartered in Kemptthal, Switzerland.

Search 201,539 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

eMolecules

San Diego, California, United States
Category Company
Founded 2005
Sector Software
DESCRIPTION

eMolecules provides business intelligence data and integrated ecommerce software for screening compound, chemical building blocks and primary antibody supply chains. eMolecules was founded in 2005 and is based in San Diego, California.

DEAL STATS #
Overall 4 of 4
Sector (Chemicals) 1 of 1
Type (Add-on Acquisition) 4 of 4
Country (Switzerland) 1 of 1
Year (2024) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-05-25 Specs

Zoetermeer, Netherlands

Specs offers chemical compound management services to the life sciences industry, particularly in the European pharmaceutical, biotechnology and academic sectors, driving time and cost efficiencies for customers' large scale drug candidate screening programs. Specs was founded in 1987 and is based in Zoetermeer, Netherlands.

Buy -
Mergr

Product

Company

Legal